Abstract:Boronic acids can interact with Lewis bases to generate boronate anions, and they can also bind with diol units to form cyclic boronate esters. Boronic acid based receptor designs originated when Lorand and Edwards used the pH drop observed upon the addition of saccharides to boronic acids to determine their association constants. The inherent acidity of the boronic acid is enhanced when 1,2-, 1,3-, or 1,4-diols react with boronic acids to form cyclic boronic esters (5, 6, or 7 membered rings) in aqueous media, and these interactions form the cornerstone of diol-based receptors used in the construction of sensors and separation systems. In addition, the recognition of saccharides through boronic acid complex (or boronic ester) formation often relies on an interaction between a Lewis acidic boronic acid and a Lewis base (proximal tertiary amine or anion). These properties of boronic acids have led to them being exploited in sensing and separation systems for anions (Lewis bases) and saccharides (diols). The fast and stable bond formation between boronic acids and diols to form boronate esters can serve as the basis for forming reversible molecular assemblies. In spite of the stability of the boronate esters' covalent B-O bonds, their formation is reversible under certain conditions or under the action of certain external stimuli. The reversibility of boronate ester formation and Lewis acid-base interactions has also resulted in the development and use of boronic acids within multicomponent systems. The dynamic covalent functionality of boronic acids with structure-directing potential has led researchers to develop a variety of self-organizing systems including macrocycles, cages, capsules, and polymers. This Account gives an overview of research published about boronic acids over the last 5 years. We hope that this Account will inspire others to continue the work on boronic acids and reversible covalent chemistry.

Targeting biomolecules with reversible covalent chemistry.

Advanced Approaches of Developing Targeted Covalent Drugs

Applications of covalent chemistry in targeted protein degradation

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

Chemoselective Reagents for the Traceless Bioreversible Modification of Native Proteins

Expanding the Chemistry of Dihaloacetamides as Tunable Electrophiles for Reversible Covalent Targeting of Cysteines

Reversible Covalent Inhibition─Desired Covalent Adduct Formation by Mass Action

New electrophiles targeting thiols in a reversible covalent manner

Covalent Inhibition in Drug Discovery

Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry

Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond

Exploiting the Reversible Covalent Bonding of Boronic Acids: Recognition, Sensing, and Assembly

Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis

Recent Advances towards the Reversible Chemical Modification of Proteins

Bind&Bite: covalently stabilized heterodimeric coiled-coil peptides for the site-selective, cysteine-free chemical modification of proteins

Recent applications of covalent chemistries in protein-protein interaction inhibitors

Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets

Covalent Probe Finds Carboxylic Acid.

Classifying covalent protein binders by their targeted binding site

Controlled Reversible N-Terminal Modification of Peptides and Proteins.